PREPROPOSAL STATEMENT OF INQUIRY
Subject of Possible Rule Making: Revision of WAC 182-50-005(9) and 182-50-200 (1)(b) to include "the refill of an immunomodulator/antiviral treatment for Hepatitis C for which an established, fixed duration of therapy is prescribed for at least twenty-four weeks but no more than forty-eight weeks" as a basis for exemption from preferred drug substitution as required by RCW 69.41.180.
Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 41.05.160.
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: To incorporate amendments to RCW 69.41.180 created by SSB 5838 (chapter 233, Laws of 2006).
Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: RCW 41.05.011(2) defines "state purchased health care" to include purchases made by several Washington state agencies including the departments of social and health services, health, labor and industries, corrections, veterans affairs, local school districts as well as the basic health and public employee programs administered by the health care authority.
Process for Developing New Rule: These rules will be adopted after discussions with affected agencies and the public.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Duane Thurman, Health Care Authority, Mailstop TB-51, 1511 Third Avenue, Suite 201, Seattle, WA 98101, (206) 521-2036, fax (206) 521-2001, email@example.com.
April 30, 2007